Fecal Calprotectin Testing Market Trends

Growth Drivers

• Rising Prevalence of Gastrointestinal Illnesses Among the Global Population – As a result of an unhealthy lifestyle, a lot of people nowadays are suffering from gastrointestinal diseases. Hence, the demand for fecal calprotectin testing is projected to grow during the forecast period. A recent report of 2022 stated that around 60 to 70 million Americans suffer from gastrointestinal diseases every year which cause serious problems in day-to-day life.

• Growing Focus on Enhancing Medical Devices – Governments of different nations are focusing on developing novel medical equipment for enhanced fecal calprotectin testing for patients. Thus, the increase in investments is attributed to creating a positive outlook for market expansion in the next few years. For instance, a recently published report stated that in India, foreign investments in the medical devices sector increased from USD 301 million in FY20 to USD 151 in FY19.

• Increasing Burden of Digestive Disorders – According to a report shared by the Centers for Disease Control and Prevention (CDC) it has been revealed that in the North American region, the number of visits to a physician regarding an issue with the digestive system totaled up to approximately 35.4% million in 2019.

• Burgeoning Geriatric Cases – As a person ages, the body weakens and the body parts start to deteriorate. As a result, the geriatric population is more prone to intestine problems such as colorectal cancers, and colon and rectum cancer. Hence, the expansion of the geriatric population is expected to increase the utilization rate of fecal calprotectin testing in the analysis period. The World Health Organization stated that by 2030, one out of six people in the world is bound to age 60 years and over.

Challenges

• High Cost of Fecal Calprotectin Testing – As fecal calprotectin testing requires technologically advanced products, the overall cost of fecal calprotectin testing increases. Thus, the population with low and middle income are not able to opt for fecal calprotectin testing which subsequently lowers the adoption rate and hinders the expansion of the market size during the forecast period.
• Low Awareness Level Among the Population About the Advantages
• Stringent Government Rules